Preventing repeat bleeding from stomach or upper gut ulcers
Treatments studied
Part of Digestive system clinical trials.
This trial studies medicines to help stop bleeding from coming back after you’ve had an “idiopathic” stomach/upper gut ulcer bleed. It may help by reducing ulcer re-bleeding risk in people who don’t have common causes like H. pylori or common ulcer-triggering drugs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’ve had a bleeding stomach or upper gut ulcer seen on endoscopy
- Your ulcer is “idiopathic,” meaning no clear cause like H. pylori or certain medicines/conditions in the prior weeks
- Your blood count (hemoglobin) is stable or back to your usual level since the last bleed
- Your age is 18 or older, and you can give consent (fingerprint is allowed if needed)
- You are not taking blood thinners or regular pain medicines like aspirin/NSAIDs or COX-2 inhibitors
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares an IV “acid-suppressing” medicine (PPI infusion) with acid pills (oral PPIs) after doctors treat a bleeding peptic ulcer endoscopically. It may help prevent re-bleeding by keeping stomach acid low while the ulcer heals.
This trial tests whether taking a high dose of omeprazole by mouth can help control bleeding from a peptic ulcer that looks high-risk on endoscopy. It may be aimed at lowering the chance of bleeding again after your procedure.
This trial tests two medicines that lower stomach acid to help stop bleeding from the stomach or intestines. It aims to find which one works better for people with this type of bleeding.
This trial tests whether a newer drug, tegoprazan, works as well as the standard drug lansoprazole for healing bleeding ulcers in the stomach or small intestine. You will get one of these drugs for 14 days and have a follow-up endoscopy to check healing.
This trial is looking at adults who have bleeding in the upper part of the stomach or gut that was caused by a medication. The goal is to learn more about how this type of bleeding happens and how to treat it.
This trial compares two types of acid-reducing medicines to see which is better at preventing re-bleeding in people who have had severe ulcer bleeding. If you qualify, you would receive either a new acid blocker or a double dose of a standard acid reducer.
Hear when a new Active Peptic Ulcer Disease/GI Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.